Why the study?
Do higher preoperative inflammatory biomarker values and specific plaque features predict 12-month restenosis and mortality in patients following carotid endarterectomy?
Do higher preoperative inflammatory biomarker values and specific plaque features predict 12-month restenosis and mortality in patients following carotid endarterectomy?
Preoperative inflammatory biomarkers and specific clinical risk factors can identify patients at high risk for restenosis and mortality after carotid endarterectomy.
Answers are grounded in this paper and cite their sources.
Preoperative inflammatory biomarkers may aid post-CEA risk stratification; leaves open causal role and need for prospective validation.
Our data revealed that higher preoperative inflammatory biomarker values highly predict 12-month restenosis and mortality following CEA. Furthermore, age above 70, unstable plaque, cardiovascular disease, and dyslipidemia were risk factors for all outcomes. Additionally, AH, AF, smoking, and obesity were all independent predictors of restenosis but not of mortality in all patients. Antiplatelet and statin medication, on the other hand, were protective against restenosis but not against mortality.
No takes yet. Share an insight, caveat, or question.
Niculescu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: